NAII icon

Natural Alternatives International

4.24 USD
+0.10
2.42%
At close Dec 20, 4:00 PM EST
1 day
2.42%
5 days
-0.93%
1 month
-4.07%
3 months
-37.19%
6 months
-32.27%
Year to date
-35.07%
1 year
-37.09%
5 years
-48.92%
10 years
-20.60%
 

About: Natural Alternatives International Inc is engaged in formulating, manufacturing, and marketing nutritional supplements. It offers vitamins, minerals, herbs, and other supplements, as well as other healthcare products to customers within the United States and internationally. Its business activity is operated through Private-Label Contract Manufacturing and Patent & Trademark Licensing segment. The company derives the majority of revenue from Private-Label Contract Manufacturing which is engaged in providing manufacturing services to companies that market and distribute nutritional supplements and other healthcare products, whereas the Patent and Trademark Licensing segment includes royalty income from its license and supply agreements associated with the sale.

Employees: 303

0
Funds holding %
of 6,809 funds
Analysts bullish %

Fund manager confidence

Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)

0% more repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 6

3.1% less ownership

Funds ownership: 33.46% [Q2] → 30.36% (-3.1%) [Q3]

14% less capital invested

Capital invested by funds: $12.5M [Q2] → $10.8M (-$1.7M) [Q3]

19% less funds holding

Funds holding: 27 [Q2] → 22 (-5) [Q3]

83% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 6

Research analyst outlook

We haven’t received any recent analyst ratings for NAII.

Financial journalist opinion

Neutral
GlobeNewsWire
1 month ago
Natural Alternatives International, Inc. Announces 2025 Q1 Results
CARLSBAD, Calif., Nov. 13, 2024 (GLOBE NEWSWIRE) -- Natural Alternatives International, Inc. ("NAI") (Nasdaq: NAII), a leading formulator, manufacturer, and marketer of customized nutritional supplements, today announced a net loss of $2.0 million, or $0.33 per diluted share, on net sales of $33.2 million for the first quarter of fiscal year 2025 compared to a net loss of $0.7 million, or $0.12 per diluted share, in the first quarter of the prior fiscal year.
Natural Alternatives International, Inc. Announces 2025 Q1 Results
Neutral
GlobeNewsWire
1 month ago
CarnoSyn® Brands Announces New U.S. Distribution Agreement With B&D Nutritional Ingredients
CARLSBAD, Calif., Oct. 24, 2024 (GLOBE NEWSWIRE) -- CarnoSyn® Brands and parent company Natural Alternatives International, Inc. (“NAI”) (Nasdaq: NAII), are pleased to announce a new distribution partnership with B&D Nutritional Ingredients, Inc., a renowned raw material distributor in the dietary supplement industry since 1993. This strategic partnership took effect on October 1st, 2024.
CarnoSyn® Brands Announces New U.S. Distribution Agreement With B&D Nutritional Ingredients
Neutral
GlobeNewsWire
2 months ago
Natural Alternatives International, Inc. Announces Fiscal 2024 Q4 and YTD Results
CARLSBAD, Calif., Sept. 27, 2024 (GLOBE NEWSWIRE) -- Natural Alternatives International, Inc. ("NAI") (Nasdaq: NAII), a leading formulator, manufacturer, and marketer of customized nutritional supplements, today announced a net loss of $1.9 million, or ($0.32) per diluted share, on net sales of $29.5 million for the fourth quarter of fiscal year 2024 compared to a net income of $2.0 million, or $0.35 per diluted share, in the fourth quarter of the prior fiscal year.
Natural Alternatives International, Inc. Announces Fiscal 2024 Q4 and YTD Results
Neutral
GlobeNewsWire
3 months ago
CarnoSyn® Brands Showcasing TriBsyn™ at the 46th ESPEN Congress On Clinical Nutrition & Metabolism
Natural Alternatives International, Inc.
CarnoSyn® Brands Showcasing TriBsyn™ at the 46th ESPEN Congress On Clinical Nutrition & Metabolism
Neutral
GlobeNewsWire
7 months ago
Natural Alternatives International, Inc. Announces Fiscal 2024 Q3 and YTD Results
CARLSBAD, Calif., May 14, 2024 (GLOBE NEWSWIRE) -- Natural Alternatives International, Inc. ("NAI") (Nasdaq: NAII), a leading formulator, manufacturer, and marketer of customized nutritional supplements, today announced a net loss of $1.6 million, or ($0.27) per diluted share, on net sales of $25.1 million for the third quarter of fiscal year 2024 compared to a net loss of $2.4 million, or ($0.41) per diluted share, in the third quarter of the prior fiscal year.
Natural Alternatives International, Inc. Announces Fiscal 2024 Q3 and YTD Results
Neutral
GlobeNewsWire
8 months ago
Natural Alternatives International Scheduled to Reopen U.S. Manufacturing Facility in California to Support Increased Production Needs
CARLSBAD, Calif., April 02, 2024 (GLOBE NEWSWIRE) -- Natural Alternatives International, Inc. (“NAI”) (Nasdaq: NAII) today announced the expected May 2024 reopening of its state-of-the-art high-volume powder blending and packaging facility located in Carlsbad, CA, following a 7-month closure.
Natural Alternatives International Scheduled to Reopen U.S. Manufacturing Facility in California to Support Increased Production Needs
Neutral
GlobeNewsWire
10 months ago
CarnoSyn® Brands Partners With Barentz for Exclusive Brazilian Distribution of CarnoSyn® Beta-Alanine
CARLSBAD, Calif., Feb. 15, 2024 (GLOBE NEWSWIRE) -- CarnoSyn® Brands and parent company Natural Alternatives International, Inc. (“NAI”) (Nasdaq: NAII), today announced its expansion in Brazil with Barentz, creating an exclusive distribution channel for CarnoSyn® beta-alanine throughout the entire Brazilian dietary supplements' market.
CarnoSyn® Brands Partners With Barentz for Exclusive Brazilian Distribution of CarnoSyn® Beta-Alanine
Neutral
GlobeNewsWire
10 months ago
Natural Alternatives International, Inc. Announces 2024 Q2 and YTD Results
CARLSBAD, Calif., Feb. 13, 2024 (GLOBE NEWSWIRE) -- Natural Alternatives International, Inc. ("NAI") (Nasdaq: NAII), a leading formulator, manufacturer, and marketer of customized nutritional supplements, today announced a net loss of $3.1 million, or $0.52 per diluted share, on net sales of $25.2 million for the second quarter of fiscal year 2024 compared to net income of $1.8 million, or $0.31 per diluted share, in the second quarter of the prior fiscal year.
Natural Alternatives International, Inc. Announces 2024 Q2 and YTD Results
Charts implemented using Lightweight Charts™